Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chione Ltd Insider Profile
4 Followers
Chione Ltd, Ten Percent Owner at Karyopharm Therapeutics, holds 3.85M shares in Acrivon Therapeutics, Inc. (Ticker: ACRV), holds 6.00M shares in Karyopharm Therapeutics (Ticker: KPTI). Most recently, Chione Ltd Sold ― shares of Acrivon Therapeutics, Inc. on Jun 28, 2023 for an estimated value of 206.88.
Chione Ltd Karyopharm Therapeutics (KPTI)Ten Percent Owner
Karyopharm Therapeutics (KPTI)
Ten Percent Owner
Ranked #16,563 out of 98,743 Corporate Insiders
Profitable Transactions
23 out of 32 Profitable Transactions
Average Return
+3.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Chione Ltd holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 30, 2014 - Sep 30, 2015
Return:+69.80%
The most profitable trade made by Chione Ltd
Chione Ltd's Trading History
Karyopharm Therapeutics
Mar 04, 2019
Ten Percent Owner
Informative Sell
617.95K
$6.42M
Acrivon Therapeutics, Inc.
Jun 28, 2023
Ten Percent Owner
Informative Sell
206.88
$31.33M
List of latest transactions for each holding click on a transaction to see Chione Ltd's performance on stock
You May Also Like
Chione Ltd insider profile FAQ
What is the percentage of profitable transactions made by Chione Ltd?
The percentage of profitable transactions made by Chione Ltd is 72%.
What is the average return per transaction made by Chione Ltd?
The average return per transaction made by Chione Ltd is 3.70%.
What stocks does Chione Ltd hold?
Chione Ltd holds: KPTI, ACRV stocks.
What was Chione Ltd’s latest transaction?
Chione Ltd latest transaction was an Informative Sell of $206.88.
What was Chione Ltd's most profitable transaction?
Chione Ltd’s most profitable transaction was an Informative Sell of KPTI stock on September 30, 2014. The return on the trade was 69.80%.
What is Chione Ltd's role in Karyopharm Therapeutics?
Chione Ltd's role in Karyopharm Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.